Oral Microbiome Changes May Predict Healthy Aging and Longevity

The oral microbiome represents an underexplored frontier in aging research, potentially serving as both a biomarker and intervention target for healthy longevity. This comprehensive review synthesizes current evidence on how oral microbial communities change throughout the aging process and their implications for health outcomes.

Researchers conducted a narrative review of existing literature examining oral microbiome composition across different age groups and health states. The oral cavity contains the body's second-largest microbial reservoir, establishing early in life and remaining relatively stable in adulthood before undergoing age-related changes influenced by factors like diet, oral hygiene, and immune function.

The findings reveal complex patterns in microbial diversity with aging. Some studies show increased diversity in older adults, while others report decreases, suggesting that diversity changes may depend on health status rather than age alone. More consistently, specific bacterial taxa show clear age-related trends: genera like Comamonas and Phocaeicola increase with age, while Veillonella, Haemophilus, and Streptococcus typically decrease. Importantly, unhealthy aging conditions including frailty, sarcopenia, and neurodegenerative diseases are associated with distinct patterns of oral dysbiosis.

The mechanisms linking oral microbiota to aging appear to center on chronic inflammation and immunosenescence. Pathogenic oral bacteria can trigger systemic inflammatory responses and may contribute to the low-grade chronic inflammation characteristic of aging. The oral-gut axis also plays a role, as oral microbes continuously seed the digestive system and influence immune responses throughout the body.

These findings suggest promising intervention strategies. Probiotics, dietary modifications, and improved oral hygiene could potentially modulate the oral microbiome to promote healthier aging. However, the field requires more research to establish causal relationships and develop targeted microbiome-based therapies for extending healthspan and longevity.